Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Public ClinicalTrials.gov record NCT07353931. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Master Protocol for Phase 3 Randomized, Double-Blind, Placebo-Controlled Studies to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Osteoarthritis Knee Pain, and Obesity or Overweight (ENLIGHTEN-4)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The YDAN master protocol will support two independent studies, J3R-MC-YOA1 and J3R-MC-YOA2. Each study will investigate how well and safely Eloralintide (LY3841136) works in adults with obesity or overweight who have osteoarthritis (OA) of the knee with pain. Participation in the study will last about 75 weeks, including screening.
Study identification
- NCT ID
- NCT07353931
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 900 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 8, 2026
- Primary completion
- Feb 29, 2028
- Completion
- Apr 30, 2028
- Last update posted
- Aug 20, 2026
2026 – 2028
United States locations
- U.S. sites
- 38
- U.S. states
- 19
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| AMR Clinical | Mobile | Alabama | 36608 | Recruiting |
| Care Access - 801 South Power Road, Mesa | Mesa | Arizona | 85206 | Recruiting |
| Elite Pain and Spine Institute - South Crimson Road | Mesa | Arizona | 85209 | Recruiting |
| Elite Clinical Studies, LLC | Phoenix | Arizona | 85018 | Recruiting |
| Tucson Orthopaedic Institute - North Wyatt Drive | Tucson | Arizona | 85712 | Recruiting |
| Ark Clinical Research - Fountain Valley | Fountain Valley | California | 92708 | Recruiting |
| Wolverine Clinical Trials | Santa Ana | California | 92706 | Recruiting |
| Encompass Clinical Research | Spring Valley | California | 91978 | Recruiting |
| Diablo Clinical Research, Inc. | Walnut Creek | California | 94598 | Recruiting |
| Skylight Health Research - Colorado Springs | Colorado Springs | Colorado | 80917 | Recruiting |
| Westside Center for Clinical Research | Jacksonville | Florida | 32205 | Recruiting |
| Care Access - St. Petersburg | St. Petersburg | Florida | 33710 | Recruiting |
| Conquest Research | Winter Park | Florida | 32789 | Recruiting |
| Orita Clinical Research | Decatur | Georgia | 30034 | Recruiting |
| Medical Research Partners | Ammon | Idaho | 83406 | Recruiting |
| Great Lakes Clinical Trials - Ravenswood | Chicago | Illinois | 60640 | Recruiting |
| Qualmedica Research, LLC | Evansville | Indiana | 47715 | Recruiting |
| AMR Clinical | Newton | Kansas | 67114 | Recruiting |
| Monroe Biomedical Research - Louisville | Louisville | Kentucky | 40213 | Recruiting |
| Skylight Health Research - Burlington | Burlington | Massachusetts | 01803 | Recruiting |
| Care Access - Quincy | Quincy | Massachusetts | 02169 | Recruiting |
| Ellipsis Research Group - Brooklyn - 7th Street | Brooklyn | New York | 11215 | Recruiting |
| Rochester Clinical Research - Buffalo | Buffalo | New York | 14127 | Recruiting |
| NYC Research INC | Long Island City | New York | 11106 | Recruiting |
| Rochester Clinical Research, LLC | Rochester | New York | 14609 | Recruiting |
| Central States Research | Tulsa | Oklahoma | 74136 | Recruiting |
| Keystone Clinical Studies | Plymouth Meeting | Pennsylvania | 19462 | Recruiting |
| JCCT - Juno Bellaire Site | Bellaire | Texas | 77401 | Recruiting |
| Epic Medical Research - DeSoto | DeSoto | Texas | 75115 | Recruiting |
| Valley Institute of Research - Fort Worth | Fort Worth | Texas | 76164 | Recruiting |
| Care Access - Houston | Houston | Texas | 77054 | Recruiting |
| VIP Trials | San Antonio | Texas | 78230 | Recruiting |
| Endeavor Clinical Trials | San Antonio | Texas | 78240 | Recruiting |
| Consano Clinical Research, LLC | Shavano Park | Texas | 78231 | Recruiting |
| Texas Valley Clinical Research | Weslaco | Texas | 78596 | Recruiting |
| AMR Clinical | South Jordan | Utah | 84095 | Recruiting |
| Charlottesville Medical Research | Charlottesville | Virginia | 22911 | Recruiting |
| Paramount Clinical Research - Data Point Clinical Research | Kirkland | Washington | 98034 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 114 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07353931, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 20, 2026 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07353931 live on ClinicalTrials.gov.